Peters Richard
Insider CIK 1697628 · MACK President and CEO, Director · YMTX President and CEO, Director · APRE Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| APRE Aprea Therapeutics, Inc. | A Award deriv | 2026-06-16 | 2026-06-17 | 12,555 | — | $0 | 12,555 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award | 2026-06-16 | 2026-06-17 | 3,135 | — | $0 | 6,254 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | P Buy deriv | 2026-03-31 | 2026-04-01 | 123,915 | — | $0 | 123,915 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | P Buy deriv | 2026-03-31 | 2026-04-01 | 123,915 | $0.81 | $100.4K | 123,915 | SEC↗ |
| KANT KINETA, INC./DE | D To issuer deriv | 2025-06-30 | 2025-07-02 | 20,000 | — | $0 | 0 | SEC↗ |
| KANT KINETA, INC./DE | D To issuer deriv | 2025-06-30 | 2025-07-02 | 12,500 | — | $0 | 0 | SEC↗ |
| KANT KINETA, INC./DE | D To issuer | 2025-06-30 | 2025-07-02 | 101,891 | — | $0 | 0 | SEC↗ |
| KANT KINETA, INC./DE | A Award | 2025-06-25 | 2025-06-25 | 6,000 | — | $0 | 101,891 | SEC↗ |
| KANT KINETA, INC./DE | M Exercise deriv | 2025-06-23 | 2025-06-25 | 12,500 | — | $0 | 0 | SEC↗ |
| KANT KINETA, INC./DE | M Exercise | 2025-06-23 | 2025-06-25 | 12,500 | $0.61 | $7.6K | 100,597 | SEC↗ |
| KANT KINETA, INC./DE | F Tax w/h | 2025-06-23 | 2025-06-25 | 4,706 | $0.26 | $1.2K | 95,891 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award deriv | 2025-06-05 | 2025-06-09 | 4,185 | — | $0 | 4,185 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award | 2025-06-05 | 2025-06-09 | 1,045 | — | $0 | 3,119 | SEC↗ |
| KA KINETA, INC./DE | A Award deriv | 2024-09-04 | 2024-09-05 | 12,500 | — | $0 | 12,500 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award deriv | 2024-06-20 | 2024-06-21 | 4,185 | — | $0 | 4,185 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award | 2024-06-20 | 2024-06-21 | 1,045 | — | $0 | 2,074 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award deriv | 2023-08-23 | 2023-08-24 | 2,000 | — | $0 | 2,000 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award | 2023-08-23 | 2023-08-24 | 500 | — | $0 | 1,029 | SEC↗ |
| KA KINETA, INC./DE | A Award deriv | 2023-04-12 | 2023-04-14 | 12,500 | — | $0 | 12,500 | SEC↗ |
| KA KINETA, INC./DE | A Award deriv | 2023-04-12 | 2023-04-14 | 20,000 | — | $0 | 20,000 | SEC↗ |
| KA KINETA, INC./DE | F Tax w/h | 2022-12-16 | 2022-12-20 | 1,931 | $1.86 | $3.6K | 88,097 | SEC↗ |
| YMTX YUMANITY THERAPEUTICS, INC | S Sale | 2022-12-02 | 2022-12-06 | 10,890 | $1.69 | $18.4K | 90,028 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award deriv | 2022-07-28 | 2022-08-01 | 29,575 | — | $0 | 29,575 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award | 2022-07-28 | 2022-08-01 | 5,995 | — | $0 | 10,605 | SEC↗ |
| YMTX YUMANITY THERAPEUTICS, INC | S Sale | 2022-07-05 | 2022-07-06 | 4,584 | $1.85 | $8.5K | 100,918 | SEC↗ |
| YMTX YUMANITY THERAPEUTICS, INC | S Sale | 2022-06-03 | 2022-06-06 | 10,206 | $1.19 | $12.1K | 105,502 | SEC↗ |
| YMTX YUMANITY THERAPEUTICS, INC | S Sale | 2022-03-28 | 2022-03-30 | 10,715 | $1.85 | $19.8K | 115,708 | SEC↗ |
| YMTX YUMANITY THERAPEUTICS, INC | A Award | 2021-12-01 | 2021-12-03 | 70,000 | — | $0 | 126,423 | SEC↗ |
| YMTX YUMANITY THERAPEUTICS, INC | F Tax w/h | 2021-07-06 | 2021-07-07 | 79 | $10.79 | $852 | 56,423 | SEC↗ |
| YMTX YUMANITY THERAPEUTICS, INC | F Tax w/h | 2021-07-02 | 2021-07-07 | 4,441 | $11.11 | $49.3K | 56,502 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award deriv | 2021-06-30 | 2021-07-01 | 22,750 | — | $0 | 22,750 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award | 2021-06-30 | 2021-07-01 | 4,610 | — | $0 | 4,610 | SEC↗ |
| YMTX YUMANITY THERAPEUTICS, INC | A Award deriv | 2021-02-01 | 2021-02-03 | 60,944 | — | $0 | 60,944 | SEC↗ |
| YMTX YUMANITY THERAPEUTICS, INC | A Award deriv | 2021-02-01 | 2021-02-03 | 120,000 | — | $0 | 120,000 | SEC↗ |
| YMTX YUMANITY THERAPEUTICS, INC | A Award | 2021-02-01 | 2021-02-03 | 60,943 | — | $0 | 60,943 | SEC↗ |
| YMTX YUMANITY THERAPEUTICS, INC | A Award deriv | 2020-12-22 | 2020-12-28 | 235,237 | — | $0 | 235,237 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award deriv | 2020-06-26 | 2020-06-29 | 7,000 | — | $0 | 7,000 | SEC↗ |
| MACK MERRIMACK PHARMACEUTICALS | J Other deriv | 2019-05-08 | 2019-05-10 | 25,000 | — | $0 | 200,000 | SEC↗ |
| MACK MERRIMACK PHARMACEUTICALS | J Other deriv | 2019-05-08 | 2019-05-10 | 225,000 | — | $0 | 0 | SEC↗ |
| MACK MERRIMACK PHARMACEUTICALS | A Award deriv | 2018-12-11 | 2018-12-13 | 225,000 | — | $0 | 225,000 | SEC↗ |
| MACK MERRIMACK PHARMACEUTICALS | A Award deriv | 2018-02-15 | 2018-02-16 | 225,000 | — | $0 | 225,000 | SEC↗ |
| MACK MERRIMACK PHARMACEUTICALS | A Award deriv | 2017-06-06 | 2017-06-07 | 2,000,000 | — | $0 | 2,000,000 | SEC↗ |